Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06645145 · ClinicalTrials.gov registry record · NA

Language Learning and Language Experience

A NA study, sponsored by Montclair State University.

Completed
Registry status
NA
Development phase
170
Enrollment target

NCT06645145: Completed NA study, sponsored by Montclair State University.

NCT06645145 is a NA study that has completed, run by Montclair State University. The registered enrollment target is 170 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06645145, a NA study, has completed, sponsored by Montclair State University.

COMPLETED
Registry status
NA
Development phase
170 participants
Enrollment target

Study Summary

The goal of this clinical trial is to learn if text can support children in learning new verbs in healthy children ages three through six. The main questions it aims to answer are: Does text support help children learn new verbs? Does a child's relative benefit from text support vary according to their literacy skills? Participants will * Watch videos of actions and hear novel words * Name alphabet sounds to determine their literacy skills

Primary Outcome

The investigators will measure accuracy in an identification task with a pointing response.

Interventions

  • BEHAVIORAL Orthographic facilitation

Trial Details

FieldValue
Enrollment Target 170 participants
Start Date 2024-10-31
Est. Completion 2025-08-30
Phase NA
Montclair State University

8 total trials

What the finished NCT06645145 record still lists

NCT06645145 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 1 intervention - of which Orthographic facilitation is the first listed.

NCT06645145 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06645145 about?

NCT06645145 is a clinical study titled "Language Learning and Language Experience". The goal of this clinical trial is to learn if text can support children in learning new verbs in healthy children ages three through six. The main questions it aims to answer are: Does text support help children learn new verbs? Does a child's relative benefit from text support vary according to t...

What is the current status of trial NCT06645145?

This trial is currently completed. It is a NA study. The enrollment target is 170 participants. The study started on 2024-10-31. Estimated completion is 2025-08-30.

What interventions are being tested in trial NCT06645145?

The interventions under investigation include: Orthographic facilitation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06645145?

This trial is sponsored by Montclair State University, which has 8 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06645145's enrollment target sits among peer trials

170 614th of 2000 higher than 1,382 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02016430 · 170 participants · NA

    Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)

  • NCT02621021 · 170 participants · Phase 2

    A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab

  • NCT04094701 · 170 participants · NA

    Hip Arthroscopy Postoperative Opioid Demands

  • NCT04166409 · 170 participants · Phase 3

    A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06645145, the US trial registry maintained by the National Library of Medicine. NCT06645145 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.